This page shows the latest Gracell Biotechnologies news and features for those working in and with pharma, biotech and healthcare.
Takes fight to Novartis and Gilead. Gracell Biotechnologies has thrown down a gauntlet to Novartis and Gilead Sciences with a CD19-targeting CAR-T for B-cell acute lymphoblastic leukaemia ... Gracell is also preparing Fast CAR therapies for NHL and other
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...